RenalSense Company
RenalSense is building a Realtime Diagnostic Platform for Acute Kidney Injury (AKI) in Critical Care: Detection, Prevention, Management
Technology:
Diagnostic Pannel
Industry:
P4 Medicine
Headquarters:
Jerusalem, Yerushalayim, Israel
Founded Date:
2009-01-01
Employees Number:
11-50
Funding Status:
N/A
Investors Number:
2
Total Funding:
14825832
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-11-22
Last Funding Type:
Series A
Register and Claim Ownership